Study of Transitioning From Alendronate to Denosumab

Clinical trial NCT00377819 · COMPLETED

Trial details

NCT number: NCT00377819
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2006-09-01
Primary completion: 2008-03-01
Enrollment: 504

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.